Estrogen and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the tamoxifen and exemestane adjuvant multinational (TEAM) trial

J. M. S. Bartlett, C. L. Brookes, C. J. H. van de Velde, L. J. Billingham, A. Hasenberg, C. Markopoulos, E. A. Mallon, R. Paridaens, C. Seynaeve, D. W. Rea

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)264-264
Number of pages1
JournalEuropean Journal of Cancer - Supplement
Volume7
Issue number2
Publication statusPublished - Sept 2009

Cite this